PCTY · Paylocity Holding Corp · Insider Trading

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.53 to $148.61, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.39 to $147.39, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.38 to $146.37, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4 and 5 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.40 to $148.36, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 27, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.34 to $159.24, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.33 to $158.33, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.02 to $158.02, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.01 to $157.01, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.03 to $158.80, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.00 to $155.94, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4 and 5 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.00 to $155.04, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.02 to $151.97, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.12 to $154.13, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.00 to $151.00, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4, 5 and 6 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.10 to $154.04, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.09 to $153.09, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 27, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.96 to $150.93, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted on September 10, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.00 to $150.98, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 27, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.93 to $149.90, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3 and 4 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted on September 10, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.66 to $150.75, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted on September 10, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.61 to $149.59, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3 and 4 of this Form 4.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on September 5, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 27, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.97 to $150.99, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted on September 10, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.62 to $150.45, inclusive.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 27, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on November 25, 2025.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on December 15, 2025.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.10 to $153.04, inclusive.

Each market stock unit (MSU) represents the contingent right to receive one (1) share of Issuer common stock.

Reflects the grant of a target number MSUs subject to the award as presented in the table. The number of MSUs that ultimately vest may be 0%-200% of this number, depending upon the achievement by the Issuer of certain total shareholder return objectives.

The MSUs have four separate performance periods, which begin August 31, 2026 and end November 30, 2028, February 28, 2029, May 31, 2029 and August 31, 2029, respectively. Twenty five percent (25%) of the total award may be earned after the end of each performance period and, to the extent earned, will vest quarterly.

Market stock units do not expire; they either vest or are canceled prior to or upon the vesting date.

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over two years beginning on the date of grant at a rate of 12.5% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest 25% quarterly, such that the RSUs will vest completely on the first anniversary of the date of grant. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over two years beginning on the date of grant at a rate of 12.5% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.

Each market stock unit (MSU) represents the contingent right to receive one (1) share of Issuer common stock.

Reflects the grant of a target number MSUs subject to the award as presented in the table. The number of MSUs that ultimately vest may be 0%-200% of this number, depending upon the achievement by the Issuer of certain total shareholder return objectives.

The MSUs have four separate performance periods, which begin August 31, 2026 and end November 30, 2028, February 28, 2029, May 31, 2029 and August 31, 2029, respectively. Twenty five percent (25%) of the total award may be earned after the end of each performance period and, to the extent earned, will vest quarterly.

Market stock units do not expire; they either vest or are canceled prior to or upon the vesting date.

Each market stock unit (MSU) represents the contingent right to receive one (1) share of Issuer common stock.

Reflects the grant of a target number MSUs subject to the award as presented in the table. The number of MSUs that ultimately vest may be 0%-200% of this number, depending upon the achievement by the Issuer of certain total shareholder return objectives.

The MSUs have four separate performance periods, which begin August 31, 2026 and end November 30, 2028, February 28, 2029, May 31, 2029 and August 31, 2029, respectively. Twenty five percent (25%) of the total award may be earned after the end of each performance period and, to the extent earned, will vest quarterly.

Market stock units do not expire; they either vest or are canceled prior to or upon the vesting date.

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over four years beginning on the date of grant at a rate of 6.25% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.

Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of Common Stock per RSU. The RSUs will vest over four years beginning on the date of grant at a rate of 6.25% vesting every three months. The grant will be settled pursuant to the terms of the Issuer's Amended and Restated 2023 Equity Incentive Plan.

The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.83 to $148.83, inclusive.